این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Archives of Anesthesiology and Critical Care، جلد ۷، شماره ۴، صفحات ۲۵۳-۲۷۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی A Possible Guide as a Tool to Complementary Effects of New Coronavirus
چکیده انگلیسی مقاله At the end of 2019, Sars-CoV-2 was identified and has since spread in the world. Coronavirus is commonly caused by the upper respiratory tract and severe acute respiratory syndrome in humans. Due to the novel nature of the virus and high mortality among high-risk people, today health care providers used several medications with different mechanisms to overcome this virus. The course of COVID-19 represents three stages that have different symptoms and used different drugs depends on each stage.  Ultimately the minority of patients progress to stage III with high mortality. The aim of this study is a comprehensive review of COVID-19 adjuvant therapies. We explained the current study on the use of Glucocorticoids, Interferon, Vitamin C, Tocilizumab, Anakinra, Pentoxifylline, IVIG, Allopurinol, Ivermectin, and Selenium in sepsis, pneumonia, and ARDS and we suggested a new protocol for prescribing each medication currently used in COVID-19 Outbreak. At the end of 2019, Sars-CoV-2 was identified and has since spread in the world. Coronavirus is commonly caused by the upper respiratory tract and severe acute respiratory syndrome in humans. Due to the novel nature of the virus and high mortality among high-risk people, today health care providers used several medications with different mechanisms to overcome this virus. The course of COVID-19 represents three stages that have different symptoms and used different drugs depends on each stage.  Ultimately the minority of patients progress to stage III with high mortality. The aim of this study is a comprehensive review of COVID-19 adjuvant therapies. We explained the current study on the use of Glucocorticoids, Interferon, Vitamin C, Tocilizumab, Anakinra, Pentoxifylline, IVIG, Allopurinol, Ivermectin, and Selenium in sepsis, pneumonia, and ARDS and we suggested a new protocol for prescribing each medication currently used in COVID-19 Outbreak.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Afsaneh Sadremomtaz
XB20 Drug Design, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, Netherlands


| Javad Hashemi
Department of Pathobiology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.


| Adeleh Sahebnasagh
Clinical Research Center, Department of Internal Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.


| Seyed Mohammad Nabavi
Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran.


| Zayana M.Al-Dahmani
Biochemistry Department, College of Medicine, Sultan Qaboos University, Alkhoud, Oman.


| Shayesteh Gheibi
Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran


| Bita Shahrami
Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran


| Reza Mosaed
Department of Anesthesiology and Intensive Care, School of Medicine, Aja University of Medical Sciences, Tehran, Iran.


| Peyman Arfa
Burn Intensive Care Unit, Shahid Motahari Burn Hospital, Iran University of Medical Sciences, Tehran, Iran


| Soheil Roshanzamiri
Burn Intensive Care Unit, Shahid Motahari Burn Hospital, Iran University of Medical Sciences, Tehran, Iran


| Mojtaba Mojtahedzadeh
Department of Clinical Pharmacy, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran
نشانی اینترنتی https://aacc.tums.ac.ir/index.php/aacc/article/view/382
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات